Cargando…

PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey

Detalles Bibliográficos
Autores principales: Minoia, F, Davì, S, Horne, A, Consolaro, A, Rosina, S, Davidsone, Z, De Cunto, C, De Inocencio, J, Eisenstein, E, Espada, G, Fishbach, M, Frosch, M, Gallizzi, R, Gamir, ML, Griffin, T, Grom, A, Hennon, T, Horneff, G, Huasong, Z, Ruperto, N, Martini, A, Cron, RQ, Ravelli, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044446/
http://dx.doi.org/10.1186/1546-0096-11-S2-P153
_version_ 1782319146411753472
author Minoia, F
Davì, S
Horne, A
Consolaro, A
Rosina, S
Davidsone, Z
De Cunto, C
De Inocencio, J
Eisenstein, E
Espada, G
Fishbach, M
Frosch, M
Gallizzi, R
Gamir, ML
Griffin, T
Grom, A
Hennon, T
Horneff, G
Huasong, Z
Ruperto, N
Martini, A
Cron, RQ
Ravelli, A
author_facet Minoia, F
Davì, S
Horne, A
Consolaro, A
Rosina, S
Davidsone, Z
De Cunto, C
De Inocencio, J
Eisenstein, E
Espada, G
Fishbach, M
Frosch, M
Gallizzi, R
Gamir, ML
Griffin, T
Grom, A
Hennon, T
Horneff, G
Huasong, Z
Ruperto, N
Martini, A
Cron, RQ
Ravelli, A
author_sort Minoia, F
collection PubMed
description
format Online
Article
Text
id pubmed-4044446
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40444462014-06-19 PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey Minoia, F Davì, S Horne, A Consolaro, A Rosina, S Davidsone, Z De Cunto, C De Inocencio, J Eisenstein, E Espada, G Fishbach, M Frosch, M Gallizzi, R Gamir, ML Griffin, T Grom, A Hennon, T Horneff, G Huasong, Z Ruperto, N Martini, A Cron, RQ Ravelli, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044446/ http://dx.doi.org/10.1186/1546-0096-11-S2-P153 Text en Copyright © 2013 Minoia et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Minoia, F
Davì, S
Horne, A
Consolaro, A
Rosina, S
Davidsone, Z
De Cunto, C
De Inocencio, J
Eisenstein, E
Espada, G
Fishbach, M
Frosch, M
Gallizzi, R
Gamir, ML
Griffin, T
Grom, A
Hennon, T
Horneff, G
Huasong, Z
Ruperto, N
Martini, A
Cron, RQ
Ravelli, A
PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title_full PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title_fullStr PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title_full_unstemmed PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title_short PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
title_sort pres-final-2141: clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044446/
http://dx.doi.org/10.1186/1546-0096-11-S2-P153
work_keys_str_mv AT minoiaf presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT davis presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT hornea presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT consolaroa presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT rosinas presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT davidsonez presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT decuntoc presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT deinocencioj presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT eisensteine presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT espadag presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT fishbachm presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT froschm presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT gallizzir presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT gamirml presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT griffint presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT groma presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT hennont presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT horneffg presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT huasongz presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT ruperton presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT martinia presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT cronrq presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey
AT ravellia presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey